Literature DB >> 25375987

Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden.

Daniel S Olsson1, Eva Andersson, Ing-Liss Bryngelsson, Anna G Nilsson, Gudmundur Johannsson.   

Abstract

CONTEXT: Craniopharyngiomas (CPs) in adults have been associated with excess mortality.
OBJECTIVE: The aim of the study was to investigate mortality and morbidity in patients with childhood-onset and adult-onset CP.
METHODS: PATIENTS with CP were identified and followed in Swedish national health registries, 1987 through 2011. The inclusion criteria for the CP diagnosis were internally validated against patient records in 28% of the study population. SETTINGS: This was a nationwide population-based study. PATIENTS: A total of 307 patients (151 men and 156 women) were identified and included (mean follow-up, 9 years; range, 0-25 years). The inclusion criteria had a positive predictive value of 97% and a sensitivity of 92%. INTERVENTION: There were no interventions. MAIN OUTCOME MEASURES: Standardized mortality ratios (SMRs) and standardized incidence ratios (SIRs) with 95% confidence intervals were calculated using the Swedish population as the reference.
RESULTS: During the study, 54 patients died compared with the expected number of 14.1, resulting in an SMR of 3.2 (2.2-4.7) for men and 4.9 (3.2-7.2) for women. PATIENTS with childhood-onset (n = 106) and adult-onset (n = 201) CP had SMRs of 17 (6.3-37) and 3.5 (2.6-4.6), respectively. PATIENTS with hypopituitarism (n = 250), diabetes insipidus (n = 110), and neither of these (n = 54) had SMRs of 4.3 (3.1-5.8), 6.1 (3.5-9.7), and 2.7 (1.4-4.6), respectively. The SMR due to cerebrovascular diseases was 5.1 (1.7-12). SIRs were 5.6 (3.8-8.0) for type 2 diabetes mellitus, 7.1 (5.0-9.9) for cerebral infarction, 0.7 (0.2-1.7) for myocardial infarction, 2.1 (1.4-3.0) for fracture, and 5.9 (3.4-9.4) for severe infection. The SIR for all malignant tumors was 1.3 (0.8-2.1).
CONCLUSIONS: This first nationwide population-based study of patients with CP demonstrated excess mortality that was especially marked in patients with childhood-onset disease and among women. Death due to cerebrovascular diseases was increased 5-fold. Hypopituitarism and diabetes insipidus were negative prognostic factors for mortality and morbidity. PATIENTS with CP had increased disease burden related to type 2 diabetes mellitus, cerebral infarction, fracture, and severe infection.

Entities:  

Mesh:

Year:  2014        PMID: 25375987     DOI: 10.1210/jc.2014-3525

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  39 in total

Review 1.  Excess mortality after craniopharyngioma treatment: are we making progress?

Authors:  Nidan Qiao
Journal:  Endocrine       Date:  2018-12-19       Impact factor: 3.633

2.  Hypopituitarism-needs modern individualized treatment.

Authors:  Daniel S Olsson; Bengt-Åke Bengtsson
Journal:  Endocrine       Date:  2016-12-21       Impact factor: 3.633

3.  Novel predictive scoring system for morbid hypothalamic obesity in patients with pediatric craniopharyngioma.

Authors:  Mohammed A Fouda; David Zurakowski; R Michael Scott; Karen J Marcus; Peter E Manley; Nicole J Ullrich; Laurie E Cohen; Liliana C Goumnerova
Journal:  Childs Nerv Syst       Date:  2020-09-04       Impact factor: 1.475

4.  A dangerous hobby? Erysipelothrix rhusiopathiae bacteremia most probably acquired from freshwater aquarium fish handling.

Authors:  E Asimaki; O Nolte; G Overesch; C Strahm
Journal:  Infection       Date:  2016-11-21       Impact factor: 3.553

5.  Efficacy and safety of bariatric surgery for craniopharyngioma-related hypothalamic obesity: a matched case-control study with 2 years of follow-up.

Authors:  M Wijnen; D S Olsson; M M van den Heuvel-Eibrink; V Wallenius; J A M J L Janssen; P J D Delhanty; A J van der Lely; G Johannsson; S J C M M Neggers
Journal:  Int J Obes (Lond)       Date:  2016-10-31       Impact factor: 5.095

6.  Prevalence and treatment of central hypogonadism and hypoandrogenism in women with hypopituitarism.

Authors:  Catharina Olivius; Kerstin Landin-Wilhelmsen; Daniel S Olsson; Gudmundur Johannsson; Åsa Tivesten
Journal:  Pituitary       Date:  2018-10       Impact factor: 4.107

Review 7.  Microsurgical removal of craniopharyngioma: endoscopic and transcranial techniques for complication avoidance.

Authors:  Saira Alli; Semra Isik; James T Rutka
Journal:  J Neurooncol       Date:  2016-05-19       Impact factor: 4.130

8.  Risk score for the prediction of severe obesity in pediatric craniopharyngiomas: relative to tumor origin.

Authors:  Danling Li; Jun Pan; Junxiang Peng; Shichao Zhang; Guanglong Huang; Xi'an Zhang; Yun Bao; Songtao Qi
Journal:  Pediatr Res       Date:  2017-12-20       Impact factor: 3.756

9.  CRANIOPHARYNGIOMA - CLINICAL AND THERAPEUTIC OUTCOME DATA IN A MIXED COHORT OF ADULT AND PAEDIATRIC CASES.

Authors:  C Capatina; M Vintila; I Gherlan; A Dumitraşcu; A Caragheorgheopol; C Procopiuc; V Ciubotaru; C Poiana
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Oct-Dec       Impact factor: 0.877

10.  Late effects in survivors treated for lymphoma as adolescents and young adults: a population-based analysis.

Authors:  Andrea C Lo; Ben Chen; Vanessa Samuel; Kerry J Savage; Ciara Freeman; Karen Goddard
Journal:  J Cancer Surviv       Date:  2021-01-16       Impact factor: 4.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.